Investment firms warned of Facebook woes before IPO, report says As more details emerge on the behind-the-scenes events surrounding Facebook's initial public offering, the more upsetting the revelations might become to individual investors. Just before Facebook went public, a large investment firm named Capital Research ... 05/23/2012 - 1:00 pm | View Link
Will Facebook Really Create 1,000 Millionaires? Facebook’s IPO has set new records for wealth hyperbole. It’s the “best investment ever!” It’s the biggest liquidity event ever! It’s about to unleash a new wealth wave in America! It’s a boon to wealth managers and Palo Alto realtors. 01/31/2012 - 11:13 pm | View Link
Report: Facebook may file for IPO this week SAN FRANCISCO – Facebook may finally be ready to go public. The social-networking behemoth is planning as early as this week to file for an initial public offering valuing the company at up to $100 billion, according to The Wall Street Journal, citing ... 01/29/2012 - 7:32 pm | View Link
Report: Facebook IPO filing next week The social network would be looking to raise around $10 billion at a valuation of between $75 billion and $100 billion. That would make Facebook the largest tech IPO of all time, so long as you exclude telecom companies like AT&T Wireless ($10.62 billion ... 01/27/2012 - 9:47 am | View Link
Facebook Could File For an IPO Next Week (Report) The event could create 1,000 new millionaires and be a $24 billion windfall for co-founder Mark Zuckerberg. Facebook could file for an initial public offering as early as next week, the Wall Street Journal reported on Friday, Jan. 27. Citing a person ... 01/27/2012 - 6:50 am | View Link
IoT InformationWeek.com: News, analysis and research for business technology professionals, plus peer-to-peer knowledge sharing. Engage with our community. 09/28/2016 - 5:16 am | View Website
Facebook, Inc. (FB) Earnings Report Date Find the latest earnings report and earnings surprise history for Facebook, Inc. (FB) at NASDAQ.com. 09/27/2016 - 8:38 am | View Website
Facebook IPO: Can Facebook Beat the Google Display Network ... Facebook Ads: Do They Even Work? See How Facebook Advertising Compares to the Google Display Network. 09/25/2016 - 12:00 pm | View Website
Facebook IPO As Facebook's shares declined below their IPO price on the second day of trading Monday, the bankers' role in supporting the stock price is taking center stage. 09/24/2016 - 7:25 pm | View Website
Facebook, Inc. (FB) Stock Report – NASDAQ.com Analyze Facebook, Inc. (FB) Company Stock Report - Get free stock reports for Facebook, Inc. and all the companies you research at NASDAQ.com. 09/20/2016 - 2:41 am | View Website
Les Miles was fired last week, just four games into his 12th season with the LSU Tigers. Along with the departure of Miles is Cam Cameron, who had been the team’s offensive coordinator since 2013. As a result of the firing, Ed Orgeron will be the interim coach for the remainder of the season, starting with today's home matchup against Missouri.
Though working Americans have different ideas on when to retire, many regard their 60s as the ideal time to exit the workforce permanently. But while the average retirement age in the U. S. today is 63, current members of the workforce may have to kiss the idea of retiring in their 60s goodbye.
An OPEC cut would likely send crude prices higher. Image source: Getty Images. On Sept. 28, OPEC, the cartel of oil-producing nations that controls more than one-third of global oil output and over 70% of the world's proven oil reserves, shocked the markets with a surprise deal that would see its total oil production fall as much as 750,000 barrels per day.
PepsiCo is best known for their carbonated soft drinks. But consumers’ preferences have shifted toward more nutritious foods. PepsiCo responded by acquiring companies in this food segment. These products, however, have much more complex supply chains than PepsiCo’s carbonated beverage value chains. First, these products require ingredients from around the world; these are global rather than regional supply chains.
Image source: PublicDomainPictures.net. When it comes to Celgene (NASDAQ: CELG), investors' focus has revolved around its megablockbuster Revlimid franchise -- and for good reason. Revlimid, an oral treatment for blood cancer indicated for use in first- and second-line multiple myeloma, brought in $5.8 billion in revenue and accounted for 63% of Celgene's total sales in 2015.